| Literature DB >> 35967226 |
Kazutoshi Tachibana1, Keita Kikuchi2, Kouhei Narayama2, Akihito Okawa1, Yu Iwashiro1, Ayaka Arihara1, Akihiko Yamauchi2.
Abstract
Objective: This study aimed to examine the feasibility and safety of minimally invasive cardiac surgery coronary artery bypass grafting using an ultrasonically skeletonized internal thoracic artery in the authors' initial experience.Entities:
Keywords: BITA, bilateral internal thoracic artery; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; CT, computed tomography; GEA, gastroepiploic artery; Harmonic scalpel; ICS, intercostal space; ITA, internal thoracic artery; LAD, left anterior descending; LITA, left internal thoracic artery; MICS CABG, minimally invasive cardiac surgery coronary artery bypass grafting; MID CABG, minimally invasive direct coronary artery bypass; OPCAB, off-pump coronary artery bypass; RA, radial artery; RITA, right internal thoracic artery; coronary artery bypass grafting; minimally invasive cardiac surgery; minimally invasive coronary artery bypass grafting; skeletonized internal thoracic artery
Year: 2022 PMID: 35967226 PMCID: PMC9366723 DOI: 10.1016/j.xjtc.2022.05.010
Source DB: PubMed Journal: JTCVS Tech ISSN: 2666-2507
Preoperative patient characteristics (N = 247)
| Age, y | 65.9 ± 11.5 |
| Male/female | 194/53 |
| Height, cm | 162.7 ± 9.4 |
| Weight, kg | 64.8 ± 12.8 |
| Stable angina | 174 (69.9%) |
| Unstable angina | 74 (29.7%) |
| Acute MI | 0 (0%) |
| Ejection fraction, % | 58.8 ± 9.2 |
| 1-vessel disease | 39 (15.7%) |
| 2-vessel disease | 70 (28.1%) |
| 3-vessel disease | 138 (55.4%) |
| Left main trunk | 59 (23.7%) |
| Diabetes mellitus | 116 (46.6%) |
| Hypertension | 186 (74.7%) |
| Smoking history | 85 (34.1%) |
| Chronic pulmonary disease | 11 (4.4%) |
| Chronic renal insufficiency | 27 (10.8%) |
| Hemodialysis | 13 (5.2%) |
| Prior myocardial infarction | 81 (32.5%) |
| Prior PCI | 53 (21.3%) |
MI, Myocardial infarction; PCI, percutaneous coronary intervention.
Figure 1Set-up for RITA harvesting via left minithoracotomy. (1) ThoraTrak MICS Retractor System (Medtronic, Inc). (2) Octopus NUVO stabilizer (Medtronic, Inc). (3) A 32-cm dissecting hook-type Harmonic scalpel (Ethicon Endo-Surgery, Inc).
Figure 2Set-up for distal anastomosis via left minithoracotomy. (1) ThoraTrak MICS Retractor System. (2) Octopus tissue stabilizer. (3) Deep pericardium sutures.
Operative characteristics
| No. of grafts | |
| 1 graft | 47 (19.0%) |
| 2 grafts | 60 (24.3%) |
| 3 grafts | 94 (38.1%) |
| 4 grafts | 46 (18.6%) |
| Use of BITA | 108 (43.4%) |
| Sequential bypass | 97 (39.3%) |
| Average distal anastomosis | 2.62 ± 1.1 |
| Aortic no-touch technique | 142 (57.0%) |
| Total arterial revascularization | 126 (50.6%) |
| Use of cardiopulmonary bypass | 3 (1.2%) |
| Conversion to sternotomy | 0 (0%) |
| Hybrid coronary revascularization | 10 (4.0%) |
| Procedure time (min) | 288.6 ± 112.7 |
BITA, Bilateral internal thoracic artery.
Distribution of conduits and target vessels (n = anastomosis)
| No | In situ ITA (n = 393) | Free ITA (n = 31) | RA (n = 39) | GEA (n = 26) | SVG (n = 223) | |||
|---|---|---|---|---|---|---|---|---|
| LITA (n = 293) | RITA (n = 100) | LITA (n = 6) | RITA (n = 25) | |||||
| Individual/composite | Individual/composite | Individual/composite | Individual/composite | Individual/composite | Individual/composite | Individual/composite | ||
| LAD | 242 | 166/2 | 65/1 | 1/1 | 0/2 | 2/0 | 0/0 | 1/2 |
| Diagonal | 64 | 23/3 | 5/2 | 0/1 | 0/4 | 0/0 | 0/0 | 23/2 |
| OM | 109 | 28/10 | 3/9 | 0/1 | 0/10 | 0/12 | 0/0 | 29/7 |
| PL | 138 | 42/8 | 1/8 | 0/2 | 0/6 | 1/6 | 0/5 | 51/8 |
| PDA | 159 | 0/11 | 1/5 | 0/0 | 0/3 | 6/12 | 18/3 | 91/9 |
| Total | 712 | 259/34 | 75/25 | 1/5 | 0/25 | 9/30 | 18/8 | 195/28 |
ITA, Internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; GEA, gastroepiploic artery; SVG, saphenous vein graft; LAD, left anterior descending; OM, obtuse marginal artery; PL, posterolateral artery; PDA, posterior descending artery.
Figure 3Scatter plot showing a liner regression between number of patients who underwent multivessel MICS CABG and total operation time. OR, Operating room.
Postoperative outcomes
| In-hospital mortality | 1 (0.4%) |
| Stroke | 0 (0%) |
| Reoperation for bleeding | 7 (2.8%) |
| Perioperative transfusion | 47 (18.9%) |
| Respiratory insufficiency | 4 (1.6%) |
| New-onset atrial fibrillation | 23 (9.3%) |
| New-onset renal failure | 2 (0.8%) |
| Pleural effusion | 39 (15.8%) |
| Surgical site infection | 5 (2.0%) |
| Median days of hospitalization (IQR) | 11.5 (9-15) |
IQR, Interquartile range.